09.02.2024 - SOLANA BEACH, Calif., Feb. 09, 2024 (GLOBE NEWSWIRE) - Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal ... Seite 1